These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors. Puls K; Schmidhammer H; Wolber G; Spetea M Molecules; 2022 Jan; 27(3):. PubMed ID: 35164182 [TBL] [Abstract][Full Text] [Related]
4. The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability. Lin AP; Ko MC ACS Chem Neurosci; 2013 Feb; 4(2):214-24. PubMed ID: 23421672 [TBL] [Abstract][Full Text] [Related]
6. The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via μ- and κ-opioid receptors. Xu B; Zhang M; Shi X; Zhang R; Chen D; Chen Y; Wang Z; Qiu Y; Zhang T; Xu K; Zhang X; Liedtke W; Wang R; Fang Q Br J Pharmacol; 2020 Jan; 177(1):93-109. PubMed ID: 31444977 [TBL] [Abstract][Full Text] [Related]
7. Peripheralization Strategies Applied to Morphinans and Implications for Improved Treatment of Pain. Schmidhammer H; Al-Khrasani M; Fürst S; Spetea M Molecules; 2023 Jun; 28(12):. PubMed ID: 37375318 [TBL] [Abstract][Full Text] [Related]
8. Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand. Parenti C; Turnaturi R; Aricò G; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Ronsisvalle G; Pasquinucci L Life Sci; 2012 Jun; 90(25-26):957-61. PubMed ID: 22580287 [TBL] [Abstract][Full Text] [Related]
9. Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid Receptors. Eans SO; Ganno ML; Mizrachi E; Houghten RA; Dooley CT; McLaughlin JP; Nefzi A J Med Chem; 2015 Jun; 58(12):4905-17. PubMed ID: 25996309 [TBL] [Abstract][Full Text] [Related]
10. Progress in the development of more effective and safer analgesics for pain management. Turnaturi R; Chiechio S; Salerno L; Rescifina A; Pittalà V; Cantarella G; Tomarchio E; Parenti C; Pasquinucci L Eur J Med Chem; 2019 Dec; 183():111701. PubMed ID: 31550662 [TBL] [Abstract][Full Text] [Related]
11. Shedding Light on the Pharmacological Interactions between μ-Opioid Analgesics and Angiotensin Receptor Modulators: A New Option for Treating Chronic Pain. Király K; Karádi DÁ; Zádor F; Mohammadzadeh A; Galambos AR; Balogh M; Riba P; Tábi T; Zádori ZS; Szökő É; Fürst S; Al-Khrasani M Molecules; 2021 Oct; 26(20):. PubMed ID: 34684749 [TBL] [Abstract][Full Text] [Related]
13. The antinociceptive effects of a dual kappa-delta opioid receptor agonist in the mouse formalin test. Ulker E; Toma W; White A; Uprety R; Majumdar S; Damaj MI Behav Pharmacol; 2020 Apr; 31(2&3):174-178. PubMed ID: 32168026 [TBL] [Abstract][Full Text] [Related]
14. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test. Chen X; Geller EB; Adler MW Eur J Pharmacol; 2007 Feb; 557(1):32-6. PubMed ID: 17173891 [TBL] [Abstract][Full Text] [Related]
15. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice. Bhalla S; Zhang Z; Patterson N; Gulati A Eur J Pharmacol; 2010 Jun; 635(1-3):62-71. PubMed ID: 20303944 [TBL] [Abstract][Full Text] [Related]
16. The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability. Yi SP; Kong QH; Li YL; Pan CL; Yu J; Cui BQ; Wang YF; Wang GL; Zhou PL; Wang LL; Gong ZH; Su RB; Shen YH; Yu G; Chang KJ Acta Pharmacol Sin; 2017 Jul; 38(7):977-989. PubMed ID: 28502978 [TBL] [Abstract][Full Text] [Related]
17. The antinociceptive properties of endomorphin-1 and endomorphin-2 in the mouse. Tseng LF Jpn J Pharmacol; 2002 Jul; 89(3):216-20. PubMed ID: 12184724 [TBL] [Abstract][Full Text] [Related]